Biocon Limited has announced that Bobby Kanubhai Parikh has completed his second term as an Independent Director and consequently ceased to be a Director of the company with effect from the close of business hours on July 22, 2026. The move marks the end of a notable chapter in Biocon’s governance as Parikh fulfilled a tenure that supported the board’s oversight during a period of dynamic change for the company.
The Board of Biocon has placed on record its deep appreciation and gratitude to Bobby Kanubhai Parikh for his extensive contribution and stewardship. Independent directors are entrusted with reinforcing governance standards and guiding strategic decision-making, and Parikh’s service is being recognized as part of Biocon’s ongoing commitment to robust board oversight.
As Biocon continues its strategic journey, the departure of an experienced independent director underscores the importance of governance refresh and continuity. The company’s leadership remains focused on sustaining robust oversight, while the board evolves to welcome new perspectives that align with Biocon’s long-term objectives.